News
Atomoxetine has been approved by the FDA as the first new drug in 30 years for the treatment of attention deficit/hyperactivity disorder (ADHD). As a selective norepinephrine uptake inhibitor and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results